Works matching IS 1082801X AND DT 2003 AND VI 38 AND IP 5

Results: 12

Adalimumab: a fully human monoclonal anti-tumor necrosis factor-alpha antibody.

Published in:

2003

By:

Edwards LA

Publication type:

Journal Article

The application of pharmacodynamics in the optimization of antibiotic therapy.

Published in:

2003

By:

Chung E;
Amsden GW;
Nafziger AN;
Bertino JS Jr.

Publication type:

Journal Article

Impact of a secondary prevention cardiovascular disease management program.

Published in:

2003

By:

Cantley L;
Holland NL;
Parker D;
Andrews L;
Knight T;
Stoukides CA;
Perdomo M

Publication type:

Journal Article

Agents for infectious disease.

Published in:: Formulary, 2003, v. 38, n. 5, p. 326
Publication type:: Article

Impact of a secondary prevention cardiovascular disease management program.

Published in:

Formulary, 2003, v. 38, n. 5, p. 320

By:

Cantley, Larry;
Holland, Nan L.;
Parker, Debbie;
Andrews, Luanne;
Knight, Thomas;
Stoukides, Cheryl A.;
Perdomo, Marianella

Publication type:

Article

The application of pharmacodynamics in the optimization of antibiotic therapy.

Published in:

Formulary, 2003, v. 38, n. 5, p. 294

By:

Chung, Ellen;
Amsden, Guy W.;
Nafziger, Anne N.

Publication type:

Article

Medication safety in the limelight.

Published in:: Formulary, 2003, v. 38, n. 5, p. 290
Publication type:: Article

Adalimumab.

Published in:

Formulary, 2003, v. 38, n. 5, p. 272

By:

Edwards, Lisa A.

Publication type:

Article

Eye on the Literature.

Published in:: Formulary, 2003, v. 38, n. 5, p. 271
Publication type:: Article

News Capsules.

Published in:: Formulary, 2003, v. 38, n. 5, p. 267
Publication type:: Article

Medication Safety and Reliability.

Published in:: Formulary, 2003, v. 38, n. 5, p. 262
Publication type:: Article

FDA Drug Approvals.

Published in:: Formulary, 2003, v. 38, n. 5, p. 253
Publication type:: Article